Use access key #2 to skip to page content.
$3.32 0.13 (4.08%)
12/4/2008 11:10 AM

Orthovita, Inc. (VITA)

CAPS Rating:
****

A spine and orthopedic biosurgery company which develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of fractures and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets

View Ticker Page (VITA)

Results 1 - 10 of 15 :   12

Recs

4

Avatar NetscribeHealthC (55.83) Submitted: 2/09/07 7:45 AM : Underperform Start Price: $3.62 VITA Score: -31.40

Orthovita is a biomaterials company involves in the development and commercialization of synthetic, biologically active, tissue engineering products for orthopedic and neurosurgical applications. Its products, used in the regeneration of bone, includ...

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar ChemFool (< 20) Submitted: 1/27/07 11:12 PM : Outperform Start Price: $3.46 VITA Score: 34.42

This company looks poised to hit profitability in 2007, and the stock looks ready to pop now. The market reacted very positively on Fri. to the implied earnings growth represented by the royalties paid to KNSY from VITA, as reported in KNSY's earnin...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar luisholl (56.48) Submitted: 4/02/07 6:00 PM : Outperform Start Price: $3.00 VITA Score: 49.47

Cotoss





I will try to be brief. I worked several years in south america in the medical industry and I also worked in the US in a medical device company. Orthovita has one of the most complete bone graft product portfolio in th...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar flexnexus (60.94) Submitted: 8/22/07 8:43 PM : Outperform Start Price: $2.83 VITA Score: 57.93

Dilution rounds look like they are finally over. Major investors have stepped up and bought more. Sales traction is already at about $60M annually with 30% growth. Cortoss is in the cusp of marketing approval in early to mid 2008. Sales of this pr...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar hg4feet (67.13) Submitted: 5/25/07 7:50 AM : Outperform Start Price: $2.99 VITA Score: 53.05

CURRENTLY NOT MAKING A PROFIT. ONE MY RISKIER PIX. CUTTING EDGE TECHNOLOGY. I BELIEVE THEIR ALLOGRAFT WITH STEM CELLS PRODUCT RAISES THE BAR COMPARED TO STANDARD ALLOGRAFT. REPRESENTED BY BLACKSTONE. I BELIEVE BOTH COMPANIES ARE ON THE RIGHT TRA...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar TMFBreakerJava (95.18) Submitted: 5/28/08 11:30 PM : Outperform Start Price: $2.39 VITA Score: 74.43

This company is steering Cortoss toward FDA approval. Cortoss is a cement that can be used to patch bone and which tends to promote bone regrowth until the bone grows into the Cortoss and replaces it.

Being tried out by orthopedic surgeons. If it ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar smegmacles (32.72) Submitted: 2/01/07 7:04 AM : Outperform Start Price: $3.50 VITA Score: 34.16

enormous potential, especially for war wounded.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar paladin65 (< 20) Submitted: 8/01/08 10:13 PM : Outperform Start Price: $2.69 VITA Score: 52.68

3 to 5 star stock in one year.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar walcat (57.48) Submitted: 4/24/08 5:19 PM : Outperform Start Price: $2.47 VITA Score: 70.18

New knees, new hips, parts is parts and some of us need more.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar dgrotefa (70.05) Submitted: 3/25/08 6:25 PM : Outperform Start Price: $2.33 VITA Score: 76.02

Their spinal based product, if passes FDA approval should prove profitable for them. An orthopedic surgeon I know says this is worth looking at. I hope he is right.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links